US Stock MarketDetailed Quotes
VRAX Virax Biolabs
- 0.6900
- -0.0100-1.43%
Close Apr 26 16:00 ET
- 0.7200
- +0.0300+4.35%
Post 16:04 ET
1.63MMarket Cap-196P/E (TTM)
0.7331High0.6650Low3.04KVolume0.6660Open0.7000Pre Close2.12KTurnover0.20%Turnover RatioLossP/E (Static)2.36MShares5.445052wk High0.18P/B1.03MFloat Cap0.613352wk Low--Dividend TTM1.50MShs Float290.0000Historical High--Div YieldTTM9.73%Amplitude0.6133Historical Low0.6980Avg Price1Lot Size
Virax Biolabs Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | |
|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||
| Cash flow from continuing operating activities | -414.76%-4.18M | -37.58%-811.99K | 20.74%-590.19K | -744.61K |
| Net income from continuing operations | -211.90%-5.46M | -160.04%-1.75M | 9.00%-672.92K | ---739.46K |
| Operating gains losses | -482,513.11%-294.27K | 101.58%61 | -494.80%-3.87K | --981 |
| Other non cash items | -93.18%20K | 987.13%293.43K | -70.24%26.99K | --90.69K |
| Change In working capital | -128.30%-182.33K | 980.99%644.39K | 161.57%59.61K | ---96.82K |
| -Change in receivables | --0 | 200.00%928 | ---928 | --0 |
| -Change in inventory | 17,214.88%20.95K | 100.57%121 | ---21.07K | --0 |
| -Change in prepaid assets | -12,707.60%-275.48K | --2.19K | --0 | ---- |
| -Change in payables and accrued expense | -94.71%33.94K | 685.62%641.16K | 184.29%81.61K | ---96.82K |
| -Change in other working capital | --38.25K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||
| Operating cash flow | -414.76%-4.18M | -37.58%-811.99K | 20.74%-590.19K | ---744.61K |
| Investing cash flow | ||||
| Cash flow from continuing investing activities | -178.4K | 0 | ||
| Net intangibles purchase and sale | ---178.4K | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||
| Investing cash flow | ---178.4K | --0 | ---- | ---- |
| Financing cash flow | ||||
| Cash flow from continuing financing activities | 1,583.33%13.69M | 38.96%813.21K | -16.95%585.2K | 704.64K |
| Net issuance payments of debt | 46.25%146.25K | --100K | --0 | ---- |
| Net common stock issuance | 2,527.79%13.65M | --519.61K | ---- | ---- |
| Net other financing activities | -157.67%-111.65K | -66.92%193.59K | -16.95%585.2K | --704.64K |
| Cash from discontinued financing activities | ||||
| Financing cash flow | 1,583.33%13.69M | 38.96%813.21K | -16.95%585.2K | --704.64K |
| Net cash flow | ||||
| Beginning cash position | 23.47%21.76K | -22.06%17.62K | -63.87%22.61K | --62.58K |
| Current changes in cash | 225,553.74%9.33M | 182.90%4.14K | 87.52%-4.99K | ---39.97K |
| End cash Position | 42,888.32%9.35M | 23.47%21.76K | -22.06%17.62K | --22.61K |
| Free cash flow | -436.73%-4.36M | -37.58%-811.99K | 20.74%-590.19K | ---744.61K |
| Currency Unit | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg